No paralogue variants have been mapped to residue 83 for KCNQ1.
KCNQ1 | ------APPASPAAPAAPPVASDL---GPR>P<PVSL------DPRVSIYSTRRPVLARTH-- | 105 |
KCNQ2 | -----------RGSILS----------KPR>A<GG--AGAGK-PPKRNAFYRK---------- | 76 |
KCNQ3 | ----QR---R----TPQ----------GIG>L<-LAKTPLSRPVKRNNAKYRR---------- | 106 |
KCNQ4 | ----L------PPGAPLP---------GPG>S<GSGSACGQR-SSAAHKRYRR---------- | 82 |
KCNQ5 | ----LRESRRGKQGARMS---------LLG>K<PL-SYTSSQ-SCRRNVKYRR---------- | 110 |
KCNA1 | YYYQSGGRLRRPVNVPLDMFSEEIKFYELG>E<EAME----K--FREDEGF------------ | 136 |
KCNA10 | YYYQSGGKIRRPANVPIDIFADEISFYELG>S<EAMD----Q--FREDEGF------------ | 185 |
KCNA2 | YYYQSGGRLRRPVNVPLDIFSEEIRFYELG>E<EAME----M--FREDEGY------------ | 132 |
KCNA3 | YYYQSGGRIRRPVNVPIDIFSEEIRFYQLG>E<EAME----K--FREDEGF------------ | 203 |
KCNA4 | YYYQSGGRLKRPVNVPFDIFTEEVKFYQLG>E<EALL----K--FREDEGF------------ | 275 |
KCNA5 | YYYQSGGRLRRPVNVSLDVFADEIRFYQLG>D<EAME----R--FREDEGF------------ | 219 |
KCNA6 | YYYQSGGRLRRPVNVPLDIFLEEIRFYQLG>D<EALA----A--FREDEGC------------ | 140 |
KCNA7 | YYYQSGGRLRRPAHVPLDVFLEEVAFYGLG>A<AALA----R--LREDEGC------------ | 112 |
KCNB1 | NFYRT-GRLHMMEEMCALSFSQELDYWGID>E<IYLE----S--CCQARYHQKKEQMNEELKR | 150 |
KCNB2 | NFYRT-GKLHMMEEMCALSFGQELDYWGID>E<IYLE----S--CCQARYHQKKEQMNEELRR | 154 |
KCNC1 | NYYRT-GKLHCPADVCGPLYEEELAFWGID>E<TDVE----P--CCWMTYRQHRDAEEALDSF | 122 |
KCNC2 | NYYRT-GKLHCPADVCGPLFEEELAFWGID>E<TDVE----P--CCWMTYRQHRDAEEALDIF | 169 |
KCNC3 | NYYRT-GKLHCPADVCGPLFEEELGFWGID>E<TDVE----A--CCWMTYRQHRDAEEALDSF | 202 |
KCNC4 | NYYRT-GKLHCPADVCGPLFEEELTFWGID>E<TDVE----P--CCWMTYRQHRDAEEALDIF | 161 |
KCND1 | NFYRT-GRLHCPRQECIQAFDEELAFYGLV>P<ELVG----D--CCLEEYRDRKKENAERLAE | 149 |
KCND2 | NFYRT-GKLHYPRHECISAYDEELAFFGLI>P<EIIG----D--CCYEEYKDRRRENAERLQD | 150 |
KCND3 | NFYRT-GKLHYPRYECISAYDDELAFYGIL>P<EIIG----D--CCYEEYKDRKRENAERLMD | 149 |
KCNF1 | EVYYF-GEVHMKKGICPICFKNEMDFWKVD>L<KFLD----D--CCKSHLSEKREELEEIARR | 144 |
KCNG1 | TFLRA-GKLRLLREMCALSFQEELLYWGIA>E<DHLD----G--CCKRRYLQKIEEFAEMVER | 182 |
KCNG2 | ALLRA-GKLRLLRGPCALAFRDELAYWGID>E<ARLE----R--CCLRRLRRREEEAAEARAG | 136 |
KCNG3 | LYVRGHGKLRFAPRMCELSFYNEMIYWGLE>G<AHLE----Y--CCQRRLDDRMSDTYTFYSA | 129 |
KCNG4 | SFLAA-GKLVLLQEMCALSFQEELAYWGIE>E<AHLE----R--CCLRKLLRKLEELEELAKL | 178 |
KCNS1 | HFYRT-GHLHVLDELCVFAFGQEADYWGLG>E<NALA----A--CCRARYLERRLTQ-PHAWD | 168 |
KCNS2 | HFYHT-GKLHVMAELCVFSFSQEIEYWGIN>E<FFID----S--CCSYSYHGRKVEPEQEKWD | 136 |
KCNS3 | NFYYT-GKLHVMEELCVFSFCQEIEYWGIN>E<LFID----S--CCSNRYQERKEENHEKDWD | 134 |
KCNV1 | HYYRT-GRLHVMEQLCALSFLQEIQYWGID>E<LSID----S--CCRDRYFRRKE-LSETLDF | 167 |
KCNV2 | NFYLS-GVLLVLDGLCPRRFLEELGYWGVR>L<KYTP----R--CCRICFEERRDELSERLKI | 216 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.P83S | c.247C>T | Putative Benign | SIFT: Polyphen: |